CSIMarket
 


Presbia Plc  (LENS)
Other Ticker:  
 

Presbia Plc's Leverage Ratio

LENS's quarterly Leverage Ratio and Total Liabilities, Equity growth


Due to net new borrowings of 71.81%, Leverage Ratio fell to 1.93, above the Presbia Plc's average Leverage Ratio.

Within Medical Equipment & Supplies industry in the forth quarter 2018, 127 other companies have achieved lower Leverage Ratio than Presbia Plc in the IV Quarter 2018. While Leverage Ratio total ranking has improved so far in the forth quarter 2018 to 2950, from total ranking in the third quarter 2018 at 2974 .

Explain Leverage Ratio?
Who are LENS Customers?
What are LENS´s Total Liabilities?


LENS Leverage Ratio (Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Equity Change -50.69 % -71.66 % -65.21 % -93.75 % -62.9 %
Y / Y Total Liabilities Change 22.83 % -44.38 % -35.07 % -11.6 % 25.44 %
Leverage Ratio MRQ 1.93 0.91 0.49 2.7 0.78
LENS's Total Ranking # 2950 # 2974 # 614 # 2708 # 1468
Seq. Equity Change -18.82 % -49.55 % 306.25 % -70.36 % -53.35 %
Seq. Total Liabilities Change 71.81 % -6.31 % -25.98 % 3.09 % -22.21 %



Leverage Ratio forth quarter 2018 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 128
Healthcare Sector # 651
Overall Market # 2950


Leverage Ratio Statistics
High Average Low
2.7 0.56 0.06
(Mar 31 2018)   (Dec 31 2015)




Financial Statements
Presbia Plc's Equity $ 2 Millions Visit LENS's Balance sheet
Presbia Plc's Total Liabilities $ 3 Millions Visit LENS's Balance sheet
Source of LENS's Sales Visit LENS's Sales by Geography


Cumulative Presbia Plc's Leverage Ratio

LENS's Leverage Ratio for the trailling 12 Months

LENS Leverage Ratio

(Dec 31 2018)
IV. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Equity TTM Growth -50.69 % -71.66 % -65.21 % -93.75 % -62.9 %
Y / Y Total Liabilities TTM Growth 22.83 % -44.38 % -35.07 % -11.6 % 25.44 %
Leverage Ratio TTM 1.12 0.88 0.68 0.51 0.32
Total Ranking TTM # 2153 # 1667 # 1344 # 1087 # 698
Seq. Equity TTM Growth -18.82 % -49.55 % 306.25 % -70.36 % -53.35 %
Seq. Total Liabilities TTM Growth 71.81 % -6.31 % -25.98 % 3.09 % -22.21 %


On the trailing twelve months basis Due to the net new borrowings of 71.81% during the trailing twelve months finishing in the IV Quarter 2018, cumulativeLeverage Ratio improved to 1.12, a new company high.
Leverage Ratio is the average cumulative value over the last four quarters.

Among companies in the Medical Equipment & Supplies industry LENS recorded the lowest Leverage Ratio. While Leverage Ratio total ranking has improved so far to 30, from total ranking in previous 12 month period at 14.

Explain Leverage Ratio?
Who are LENS Customers?
What are LENS´s Total Liabilities?

TTM Leverage Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 1
Healthcare Sector # 1
Within the Market # 2950


trailing twelve months Leverage Ratio Statistics
High Average Low
1.12 0.37 0.08
(Dec 31 2018)   (Mar 31 2016)




Companies with similar Leverage Ratio in the quarter ending Dec 31 2018, within Medical Equipment & Supplies Industry Leverage RatioDec 31 2018 MRQ Total LiabilitiesDec 31 2018 MRQ Equity
Yunhong Green Cti Ltd   5.04 $ 31.533  Millions$ 6.256  Millions
T2 Biosystems Inc   4.57 $ 52.092  Millions$ 11.387  Millions
Airxpanders Inc  4.30 $ 19.478  Millions$ 4.526  Millions
Clearpoint Neuro Inc   4.20 $ 6.346  Millions$ 1.511  Millions
Valeritas Holdings Inc.  3.80 $ 54.331  Millions$ 14.289  Millions
Microbot Medical Inc   3.61 $ 4.768  Millions$ 1.322  Millions
Plus Therapeutics Inc   3.59 $ 18.766  Millions$ 5.225  Millions
Insulet Corporation  3.37 $ 715.461  Millions$ 212.099  Millions
Milestone Scientific Inc   3.18 $ 4.861  Millions$ 1.528  Millions
3m Company  2.71 $ 26,704.000  Millions$ 9,848.000  Millions
Icad Inc  2.59 $ 17.871  Millions$ 6.896  Millions
Biolase Inc   2.47 $ 27.427  Millions$ 11.089  Millions
Vivani Medical Inc   2.46 $ 7.598  Millions$ 3.084  Millions
Infusystem Holdings Inc  2.13 $ 43.632  Millions$ 20.441  Millions
Micron Solutions Inc  2.00 $ 8.193  Millions$ 4.088  Millions
Novocure Limited  2.00 $ 224.851  Millions$ 112.259  Millions
Presbia Plc  1.93 $ 2.986  Millions$ 1.544  Millions
Dexcom Inc   1.89 $ 1,252.700  Millions$ 663.300  Millions
Helius Medical Technologies inc   1.82 $ 17.973  Millions$ 9.854  Millions
Hill rom Holdings Inc   1.80 $ 2,798.800  Millions$ 1,551.500  Millions
Genmark Diagnostics Inc   1.77 $ 59.434  Millions$ 33.547  Millions
Itamar Medical Ltd   1.75 $ 11.704  Millions$ 6.688  Millions
Apollo Endosurgery inc   1.58 $ 45.638  Millions$ 28.830  Millions
Logicmark Inc   1.58 $ 23.319  Millions$ 14.737  Millions
Msa Safety Incorporated  1.52 $ 974.130  Millions$ 639.519  Millions
Avinger Inc   1.51 $ 14.239  Millions$ 9.460  Millions
Henry Schein Inc  1.48 $ 5,227.039  Millions$ 3,541.788  Millions
Mimedx Group Inc   1.47 $ 73.189  Millions$ 49.655  Millions
Becton Dickinson And Company  1.47 $ 31,528.000  Millions$ 21,404.000  Millions
Invacare Holdings Corporation  1.47 $ 526.708  Millions$ 359.147  Millions

Date modified: -0001-11-30T00:00:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com